Daojuan Li

739 total citations
39 papers, 485 citations indexed

About

Daojuan Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Daojuan Li has authored 39 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Daojuan Li's work include Global Cancer Incidence and Screening (10 papers), Colorectal Cancer Screening and Detection (7 papers) and Cancer Risks and Factors (6 papers). Daojuan Li is often cited by papers focused on Global Cancer Incidence and Screening (10 papers), Colorectal Cancer Screening and Detection (7 papers) and Cancer Risks and Factors (6 papers). Daojuan Li collaborates with scholars based in China, United States and Japan. Daojuan Li's co-authors include Yutong He, Di Liang, Jin Shi, Wanqing Chen, Jie He, Rongshou Zheng, Baoen Shan, Baoen Shan, Hongmei Zeng and Jianghui Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Cancer.

In The Last Decade

Daojuan Li

38 papers receiving 480 citations

Peers

Daojuan Li

ONCOL

PRM

SURGE

Xiaolian Song China

Wenxi Yu China

Travis J. Meyers United States

Yannan Yuan China

You Guo China

Kun‐Chieh Chen Taiwan

Jin‐Mei Piao China

Yuyao Zhu China

Shaohua Ma China

Hae-Seong Nam South Korea

Xiaolian Song China

Daojuan Li

176 ×1.0

136 ×0.8

ONCOL

201 ×1.4

PRM

138 ×1.3

62 ×0.8

SURGE

Citations per year, relative to Daojuan Li Daojuan Li (= 1×) peers Xiaolian Song

Countries citing papers authored by Daojuan Li

Since Specialization

Citations

This map shows the geographic impact of Daojuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daojuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daojuan Li more than expected).

Fields of papers citing papers by Daojuan Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daojuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daojuan Li. The network helps show where Daojuan Li may publish in the future.

Co-authorship network of co-authors of Daojuan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Daojuan Li. A scholar is included among the top collaborators of Daojuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daojuan Li. Daojuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Daojuan, et al.. (2024). Analysis of the incidence and mortality trends of esophageal cancer in cancer registry areas of China and Japan. International Journal of Cancer. 155(8). 1376–1386. 6 indexed citations

Liang, Di, et al.. (2023). Evaluation of a population-based breast cancer screening in North China. Journal of Cancer Research and Clinical Oncology. 149(12). 10119–10130. 3 indexed citations

Liu, Yanyu, et al.. (2023). Effect of high-level PM2.5 on survival in lung cancer: a multicenter cohort study from Hebei Province, China. Environmental Science and Pollution Research. 30(34). 82094–82106. 4 indexed citations

Li, Daojuan, et al.. (2023). Stratifin (SFN) Regulates Cervical Cancer Cell Proliferation, Apoptosis, and Cytoskeletal Remodeling and Metastasis Progression Through LIMK2/Cofilin Signaling. Molecular Biotechnology. 66(11). 3369–3381. 9 indexed citations

Shi, Jin, et al.. (2023). Cost-effectiveness evaluation of risk-based breast cancer screening in Urban Hebei Province. Scientific Reports. 13(1). 3370–3370. 2 indexed citations

Zhang, Shuo, et al.. (2023). Machine learning for predicting the survival in osteosarcoma patients: Analysis based on American and Hebei Province cohort. SHILAP Revista de lepidopterología. 23(5). 883–893. 4 indexed citations

Li, Daojuan, Jin Shi, Di Liang, Meng Ren, & Yutong He. (2023). Lung cancer risk and exposure to air pollution: a multicenter North China case–control study involving 14604 subjects. BMC Pulmonary Medicine. 23(1). 182–182. 6 indexed citations

Jin, Jing, et al.. (2022). Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency. Frontiers in Oncology. 12. 871483–871483. 13 indexed citations

Li, Daojuan, Jin Shi, Xiao‐Ping Dong, et al.. (2022). Epidemiological characteristics and risk factors of lung adenocarcinoma: A retrospective observational study from North China. Frontiers in Oncology. 12. 892571–892571. 12 indexed citations

10.

Jin, Jing, et al.. (2022). Baicalein Inhibits the Progression and Promotes Radiosensitivity of Esophageal Squamous Cell Carcinoma by Targeting HIF-1A. Drug Design Development and Therapy. Volume 16. 2423–2436. 17 indexed citations

11.

Liang, Di, et al.. (2022). Participation and Yield of a Lung Cancer Screening Program in Hebei, China. Frontiers in Oncology. 11. 795528–795528. 12 indexed citations

12.

He, Yutong, Di Liang, Daojuan Li, et al.. (2020). Incidence and mortality of laryngeal cancer in China, 2015. Chinese Journal of Cancer Research. 32(1). 10–17. 37 indexed citations

13.

Liang, Di, Jingxi Wang, Daojuan Li, et al.. (2019). Lung Cancer in Never-Smokers: A Multicenter Case-Control Study in North China. Frontiers in Oncology. 9. 1354–1354. 16 indexed citations

14.

He, Yutong, Daojuan Li, Di Liang, et al.. (2018). [Incidence and mortality of bladder cancer in China, 2014].. PubMed. 40(9). 647–652. 21 indexed citations

15.

He, Yutong, Di Liang, Daojuan Li, et al.. (2017). Cancer incidence and mortality in Hebei province, 2013. Medicine. 96(26). e7293–e7293. 14 indexed citations

16.

Liang, Di, et al.. (2017). Gastric cancer burden of last 40 years in North China (Hebei Province). Medicine. 96(2). e5887–e5887. 17 indexed citations

17.

He, Yutong, et al.. (2015). [Incidence and mortality of cancers appeared in the Hebei provincial cancer registry system in 2011].. PubMed. 36(8). 846–51. 3 indexed citations

18.

Li, Daojuan. (2015). Epidemiological Trends of Colorectal Cancer. Zhongliu fangzhi yanjiu. 42(3). 305–310. 5 indexed citations

19.

Xie, Wei, Daojuan Li, Juan Zhang, et al.. (2014). Generation and characterization of a novel human IgG1 antibody against vascular endothelial growth factor receptor 2. Cancer Immunology Immunotherapy. 63(9). 877–888. 14 indexed citations

20.

Li, Haixin, Wanlu Cao, Zhiguo Chen, et al.. (2013). The antiangiogenic activity of a soluble fragment of the VEGFR extracellular domain. Biomedicine & Pharmacotherapy. 67(7). 599–606. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact